ACHV
Achieve Life Sciences, Inc.NASDAQHealthcare$3.23+2.87%ClosedMarket Cap: $172.0M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
8.00
P/S
0.00
EV/EBITDA
-3.08
DCF Value
$0.12
FCF Yield
-28.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-204.1%
ROA
-130.8%
ROIC
-150.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-14.7M | $-14.7M | $-0.28 | — |
| FY 2025 | $0.00 | -Infinity% | $-54.9M | $-54.6M | $-1.25 | — |
| Q3 2025 | $0.00 | -Infinity% | $-14.7M | $-14.4M | $-0.28 | — |
| Q2 2025 | $0.00 | NaN% | $-12.6M | $-12.7M | $-0.37 | — |
| Q1 2025 | $0.00 | NaN% | $-12.9M | $-12.8M | $-0.37 | — |
| Q4 2024 | $0.00 | NaN% | $-12.2M | $-12.4M | $-0.36 | — |
| FY 2024 | $0.00 | -Infinity% | $-39.1M | $-39.8M | $-1.24 | — |
| Q3 2024 | $0.00 | NaN% | $-12.5M | $-12.5M | $-0.36 | — |
| Q2 2024 | $0.00 | NaN% | $-8.4M | $-8.5M | $-0.25 | — |
| Q1 2024 | $0.00 | NaN% | $-6.0M | $-6.5M | $-0.26 | — |
| Q4 2023 | $0.00 | NaN% | $-4.4M | $-5.5M | $-0.26 | — |
| FY 2023 | $0.00 | NaN% | $-27.3M | $-29.8M | $-1.50 | — |